Intrexon | XON - Trade Debtors


Intrexon reported $1.02M in Trade Debtors for its fiscal quarter ending in June of 2024.





Trade Debtors Change Date
Agenus USD 22.44M 1.14M Dec/2025
Alaunos Therapeutics USD 2K 0 Jun/2025
Amgen USD 9.14B 432M Mar/2026
Anika Therapeutics USD 29.33M 661K Dec/2025
Arrowhead Research USD 218.87M 212.05M Dec/2025
AstraZeneca USD 17.88B 1.17B Mar/2026
Bristol-Myers Squibb USD 14.36B 164M Mar/2026
Gilead Sciences USD 4.91B 182M Dec/2025
GlaxoSmithKline GBP 7.94B 178M Mar/2026
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Incyte USD 1.05B 27.09M Mar/2026
Intrexon USD 1.02M 559K Jun/2024
Karyopharm Therapeutics USD 26.18M 5.6M Dec/2025
Ligand Pharmaceuticals USD 58.1M 15.98M Sep/2025
MacroGenics USD 13.37M 55.86M Dec/2025
MannKind USD 38.37M 20.98M Dec/2025
Merck USD 11.78B 345M Dec/2025
Novartis USD 9.6B 2.69B Mar/2026
Rigel Pharmaceuticals USD 28.9M 1.39M Jun/2024
Roche Holding CHF 11.9B 460M Dec/2025
Sangamo BioSciences USD 581K 110K Jun/2024
Thermo Fisher Scientific USD 9.2B 304M Mar/2026
Veracyte USD 44.66M 3.17M Dec/2025
Xencor USD 29.3M 7.49M Dec/2025